MALOBERTI ALESSANDRO

D'Elia, L., Masulli, M., Virdis, A., Casiglia, E., Tikhonoff, V., Angeli, F., et al. (2025). Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project). THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 110(2 (1 February 2025)), 470-477 [10.1210/clinem/dgae170]. Detail

Maloberti, A., Colombo, V., Daus, F., De Censi, L., Abrignani, M., Temporelli, P., et al. (2025). Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 35(3(March 2025)) [10.1016/j.numecd.2024.103792]. Detail

Russo, E., Viazzi, F., Pontremoli, R., Angeli, F., Barbagallo, C., Berardino, B., et al. (2025). Predictive value of TG/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study. LIPIDS IN HEALTH AND DISEASE, 24(1) [10.1186/s12944-025-02440-w]. Detail

Maloberti, A., Garofani, I., Giannattasio, C. (2025). Reply to: “Uric acid in metabolic syndrome: An innocent bystander or a central player?”. INTERNATIONAL JOURNAL OF CARDIOLOGY, 421(15 February 2025) [10.1016/j.ijcard.2024.132922]. Detail

Tognola, C., Bernasconi, D., Myriam Intravaia, R., Brioschi, G., Toscani, G., Algeri, M., et al. (2025). Prevalence of hypertriglyceridemia and its association with extreme cardiovascular risk in patients with acute and chronic coronary syndrome enrolled in a cardiac rehabilitation program. INTERNATIONAL JOURNAL OF CARDIOLOGY, 439 [10.1016/j.ijcard.2025.133608]. Detail